Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00449982 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts
A Phase 3 study of Condylomata Acuminata, sponsored by MediGene.
- Completed
- Registry status
- Phase 3
- Development phase
- 480
- Enrollment target
- 12
- Study locations
NCT00449982: Completed Phase 3 study of Condylomata Acuminata, sponsored by MediGene.
NCT00449982 is a Phase 3 study of Condylomata Acuminata that has completed, run by MediGene. The registered enrollment target is 480 participants, above the 21-participant average among 3 other Condylomata Acuminata trials with a reported enrollment target (2186% higher). The trial reports 12 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00449982, a Phase 3 study of Condylomata Acuminata, has completed, sponsored by MediGene.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 480 participants
- Enrollment target
- 12
- Study locations
Study Summary
The purpose of this study is to investigate the clinical efficacy, safety and tolerability of a Polyphenon E Ointment 10% and a Polyphenon E Ointment 15% in the treatment of external genitial warts in male and female patients.
Conditions Studied
Interventions
- DRUG Polyphenon E Ointment 10%, Polyphenon E Ointment 15%
Study Locations (12)
Other
- - Buenos Aires
- - Santiago, Temuco
- - Colombia, Bogota, Medellin, Risaralda
- - Cuautitlan, Mexico, Guadalajara, Durango, Ciliacan, Puebla
- - Lima, Calao
- - Bucaresti, Brasov, Iasi, Cluj-Napoca
California
- - Davis, San Diego
Colorado
- - Denver
New York
- - New York
Oregon
- - Portland
Texas
- - Houston, Dallas, Austin
Vermont
- - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2003-07 |
| Est. Completion | 2004-08 |
| Phase | Phase 3 |
What the finished NCT00449982 record still lists
NCT00449982 is an interventional study that assigns participants to a tested intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap, above the 21-participant average among 3 other Condylomata Acuminata trials with a reported enrollment target (2186% higher).
The record links to 1 condition, with Condylomata Acuminata appearing as the primary indexed condition, and to 1 intervention - of which Polyphenon E Ointment 10%, Polyphenon E Ointment 15% is the first listed.
NCT00449982 lists 12 locations in 7 states (Other, California, Colorado).
Frequently Asked Questions
What is clinical trial NCT00449982 about?
NCT00449982 is a clinical study titled "Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts". The purpose of this study is to investigate the clinical efficacy, safety and tolerability of a Polyphenon E Ointment 10% and a Polyphenon E Ointment 15% in the treatment of external genitial warts in male and female patients.
What is the current status of trial NCT00449982?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 480 participants. The study started on 2003-07. Estimated completion is 2004-08.
What conditions does trial NCT00449982 study?
This clinical trial studies the following conditions: Condylomata Acuminata.
What interventions are being tested in trial NCT00449982?
The interventions under investigation include: Polyphenon E Ointment 10%, Polyphenon E Ointment 15% (DRUG).
Who is sponsoring clinical trial NCT00449982?
This trial is sponsored by MediGene, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00449982 being conducted?
This trial has 12 study locations across California, Colorado, New York, Oregon, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Condylomata Acuminata
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01954992 · 480 participants · Phase 3
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
- NCT03023696 · 480 participants · NA
Can Prophylactic Foraminotomy Prevent C5 Palsy
- NCT04948060 · 480 participants · NA
Tribally Engaged Approaches to Lung Screening (TEALS)
- NCT05053230 · 480 participants · NA
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia